Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC
Clinical trial NCT05021328 · COMPLETED
Trial details
- NCT number
- NCT05021328
- Sponsor
- Hubei Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2025-02-05
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.